Title
Category
Credits
Event date
Cost
  • S.U.D
$0.00
Dr. San Bartolome provides case studies and information about managing care for complex patients with addictions who use more than one substance (polysubstance use).Learning Objectives:At the end of this session, learners should be able to:Identify key safety considerations when treating complex, polysubstance use cases for MAT, andExplain 2 strategies for addressing complicated inductions involving methadone and fentanyl.
  • Clinical Forum/POP!
  • Women's Health
$0.00
Learn a streamlined approach for providing medication abortions and miscarriage management. We will discuss how to safely and effectively provide this care in an evolving legal landscape.This session was recorded on August 26, 2023 as part of 2023 Family Medicine POP! Information is current as of that date.Learning Objectives:At the end of this session, learners should be able to:
  • Clinical Forum/POP!
  • Miscellaneous
$0.00
The COVID-19 Public Health Emergency has ended, but with ten to twenty percent of those affected suffering from some form of Post-COVID Condition, also known as Long COVID, family physicians are left with the uncomfortable legacy of figuring out how to care for this poorly defined chronic symptom complex. There is an urgent need for better understanding of the many manifestations of this condition, its pathophysiology, clinical management, and emerging best practices and symptom-directed treatments.
  • Clinical Forum/POP!
  • Women's Health
$0.00
Although Behavioral Health Integration is one of the three clinical focus areas identified by the California Department of Health Care Services in their 10-year vision for Medi-Cal, primary care providers may have varying degrees of Behavioral Health Integration experience and exposure. In this session, we will share our organization's eleven-year journey towards Behavioral Health Integration, including pitfalls, pearls, and lessons learned.This session was recorded on August 26, 2023 as part of 2023 Family Medicine POP! Information is current as of that date.
  • S.U.D
$0.00
This program will help overcome barriers to California providers wishing to begin offering Medication for Opioid Use Disorder (MOUD) and provide effective education to all interested family physicians. Patient-facing healthcare providers will learn to recognize OUD stigma, communicate more effectively, and be more confident in choosing MOUD.
  • Diabetes
  • 1.00 AAFP Prescribed
  • 1.00 AOA Category 2-A
$0.00
This interactive, case-based activity provides education on the clinical characteristics of the GLP-1 RAs, how they differ from each other, and the rationale and guidance for their use with patients with Type 2 Diabetes (T2D). Participants will encounter clinical case scenarios on personalizing treatment with GLP-1 RAs, taking into account patient characteristics and preferences, adherence, and management of side effects.Learning Objectives:At the end of this session, learners should be able to:
  • S.U.D
  • 1.25 AAFP Prescribed
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. Learning Objectives:At the end of this session, learners should be able to:
$0.00
These activities are part of the education provided for the California Residency Program Collaborative (CRPC) and available to providers to improve education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medications for opioid use disorder. The CRPC series offers terrific education modules to help providers identify and serve their patients with OUD/SUD. For more information, go to www.familydocs.org/crpc.
  • S.U.D
  • Pain Management
  • 3.00 AAFP Prescribed
  • 3.00 AMA PRA Category 1 Credit™
$0.00
The curriculum, Pain Management and Opioids: Balancing Risks and Benefits, meets the latest FDA Blueprint and CDC guidelines for opioid prescribing and pain management, and includes the impact of COVID-19, new pain relieving treatments, and telehealth. This education includes California state-specific information and counts towards California CME requirements for pain management and opioid prescribing practices.This activity meets the new DEA CME requirement when renewing or obtaining your DEA license.
  • S.U.D
  • 1.00 AAFP Prescribed
  • 1.00 AMA PRA Category 1 Credit™
$0.00
People with substance use disorders (SUD) are coming to the office, whether we know it or not. Let's treat SUD/OUD (opioid use disorder) as we would treat any other medical condition: with compassion and good medicine. In this webinar you’ll learn to recognize stigma, communicate more effectively, and be more confident in choosing Medication for OUD (MOUD). Addiction medicine is family medicine.Learning Objective:At the end of this session, learners should be able to:Identify common barriers to health care practitioners beginning MOUD

Pages